Visions but Not False Promises Should Be FundedKarel Petrak*
NangioTx Inc., 220 W 98th, Apt 10N, New York, NY 10025, USA
- *Corresponding Author:
- Karel Petrak
NangioTx Inc., 220 W 98th
Apt 10N, New York
NY 10025, USA
E-mail: [email protected]
Received date: June 03, 2016; Accepted date: June 07, 2016; Published date: June 10, 2016
Citation: Petrak K (2016) Visions but Not False Promises Should Be Funded. J Develop Drugs 5:154. doi:10.4172/2329-6631.1000154
Copyright: © 2016 Petrak K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Efforts to develop cell-specific drug-delivery systems have been under way for decades but have not as yet generated effective and reliable therapeutic products. The effect of repeatedly unfulfilled promises is starting to cause a decrease in funding support for research and development in this area. In this commentary, principle flaws in the current approaches are listed and discussed. Further, the manner in which approaches and paradigms for further development should change is suggested.